Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting cancer-related enzymes such as EGFR and VEGFR. Its structure supports high binding affinity to ATP sites in kinases, making it valuable in developing antitumor agents. Also explored in the design of anti-inflammatory drugs due to its ability to modulate signaling pathways involved in cell proliferation and immune response. Shows potential in improving metabolic stability and bioavailability in drug candidates.